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As multidrug resistance gains momentum, the last two decades have seen an ever-growing interest in the antimicrobial 
properties of plant extracts and plant-derived compounds. Most of the focus is on polyphenols – a large and diverse group 
of phytochemicals with strong antibacterial activity. Testing methods provide reliable results as long as they follow 
standard procedures. However, methods and procedures used in antimicrobial susceptibility testing (AST) are often too 
diverse to allow comparison of results. The lack of uniformity and comparability is much owed to the absence of guidelines. 
The focus of this review is to give a critical overview of different methods used in the assessment of polyphenols 
antimicrobial efficacy and to highlight the importance of their standardisation.
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Over the past few decades, the search for antimicrobials 
derived from plants has accelerated, as bacterial resistance 
to antibiotics grows and new, clinically useful antibiotics 
fail to emerge. Research has focused on screening raw 
materials for new natural substances to replace synthetics. 
To protect themselves from microbial pathogens plants 
produce numerous secondary metabolites with antimicrobial 
properties, such as phenolic compounds, terpenoids, 
essential oils, alkaloids, lectins, and polypeptides (1). One 
of the largest and most widespread groups of plant 
chemicals with a diverse array of positive health effects are 
polyphenols. They exhibit significant antibacterial, 
antioxidant,  anti-inflammatory, anticancer, and 
antihypertensive activity, largely attributed to interaction 
with cellular signalling pathways under normal and 
pathological conditions (2).
Polyphenols can be simple compounds with a single 
aromatic ring and low molecular weight or large and 
complex substances. Considering their chemical structure, 
they are generally divided in two groups: flavonoids and 
non-flavonoids. Flavonoids include flavones (luteolin), 
flavonols (quercetin), flavanones, flavanols (catechin, 
epicatechin), isoflavones, and anthocyanidins, while non-
flavonoides include phenolic acids (benzoic and cinnamic 
acids), phenolic alcohols (tyrosol, hydroxytyrosol), 
stilbenes, and lignans (3). A number of phenolic compounds 
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of plants used in traditional medicine (4) appear to have 
structures and modes of action that are different to those of 
antibiotics, which renders the risk of cross-resistance highly 
improbable makes them a potentially new class of antibiotic 
drug candidates or, more likely, resistance modifying agents 
in combination therapy with conventional antibiotics. 
Synergistic studies show promise against pathogens 
resistant to conventional antibiotics (5, 6). The last decade 
has seen growing evidence that plant-derived compounds 
can restore the clinical application of older antibiotics that 
are generally ineffective alone.
Even though their mechanisms of action are not fully 
clarified, polyphenols seem to damage bacterial cell 
membranes or interfere with the production of amino acids 
needed for bacterial growth (7). They also seem to modify 
bacterial resistance by inhibiting bacterial efflux pumps that 
expel antibiotics or by inhibiting enzymes that inactivate 
them (8–15).
Bacterial susceptibility to conventional antibiotics is 
determined by a number of phenotypic and genotypic 
antimicrobial susceptibility testing (AST) methods available 
in clinical laboratories. The selection of optimal method is 
based on factors such as flexibility, practicality, automation, 
cost, accuracy, reliability, and reproducibility. However, 
with plant-derived compounds additional problems arise, 
because natural products are complex mixes of many 
compounds that may not act as expected in the test system. 
For this reason, only a few AST methods have found 
application in determining antibacterial activity of natural 
products. However, AST methods provide reliable results 
only when they follow standardised procedures. Otherwise, 
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differences in experimental conditions can lead to large 
variations (16, 17). As the use of AST methods faces 
numerous challenges with polyphenols, the aim of this 
mini-review is to take a critical look at them and highlight 
the importance of their standardisation.
FACTORS INFLUENCING AST METHODS
Solvents used for polyphenol extraction/solution and 
culture media
Plant extracts are natural products, and their chemical 
composition varies. Screening crude plant extracts for 
desired bioactivity is one of the most important operations 
in the study of medicinal plants, and extraction is the first 
crucial step. The quality of plant extracts depends on plant 
material (part of the plant used fresh or dried), which may 
vary with climate, time of harvest, extraction method, 
solvent used, and (in)stability of constituents (18). This 
variation is also true for polyphenolic extracts. Extraction 
methods usually vary in length, pH, temperature, particle 
size, and solvent-to-sample ratio, which also affects the 
quantity and quality of constituents obtained. This is why 
plant extraction methods should be standardised or 
harmonised to allow direct comparison of AST results.
Most phenolic compounds with antimicrobial activity 
are aromatic or saturated organic compounds and are usually 
obtained through initial ethanol extraction. Ethanol, 
however, can interfere with the bioassay. Its presence, even 
in very small amounts, can inhibit the growth of some 
microorganisms and affect test results. In concentrations 
>2.5 % it has toxic effects on some of food poisoning 
bacteria such as the Listeria and Staphylococcus genera 
(19, 20). Other solvents used are acetone, methanol, 
chloroform, water, and dimethyl sulphoxide (DMSO) 
(21–24). DMSO is frequently used because it dissolves both 
organic and inorganic compounds well. However, as an 
antioxidant it has also been reported to protect bacteria from 
death by antimicrobials in concentrations as low as 1 % 
(25) and that its use as an extraction solvent should be 
reconsidered. Recent research has focused on new, 
sustainable, and environmentally safe extraction solvents 
such as supercritical fluids. For example, pure supercritical 
carbon dioxide is safe and may significantly enhance the 
efficiency of ethanol extraction (26).
To account for the possible influence of solvents on AST 
results testing should include not only plant extracts but 
also the antibacterial effect of the growth medium 
containing solvent (negative control). In addition, testing 
should include a standard antibiotic as positive control 
against which to compare the activity of the extract or 
polyphenolic compound.
With respect to growth media used for AST, Müller-
Hinton (MH) broth/agar is a standard for testing the 
susceptibility of non-fastidious microorganisms to 
antibiotics. The use of another culture medium may lead to 
discrepancy in results such as the one observed in two 
studies of phenolic resveratrol antimicrobial activity (27, 
28). Although both used the same reference bacterial strain, 
the minimum inhibitory concentration (MIC) of resveratrol 
was 0.1 mg/mL when the MH broth was used (27) and over 
1 mg/mL when the Luria-Bertani broth was used (28). 
Variations in results are possible even with the recommended 
MH culture media due to differences in their activity and 
composition. Even standardised components and procedures 
require quality control (QC) to ensure reliable results. QC 
testing involves reference bacterial strains to yield MIC and 
zone diameter values within recommended ranges. Ahman 
et al. (29) evaluated 21 internationally available brands of 
MH dehydrated media using a standardised disc diffusion 
method only to find that the inhibition zone diameters for 
QC reference strains were outside the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) QC 
criteria (30) for all but six tested brands. Authors also 
reported major differences in cation content and pH between 
the agars. MH agars of poor quality can affect susceptibility 
tests to the point that they produce false positive or negative 
findings. Therefore, users should evaluate the performance 
of the media they use and confirm that QC criteria published 
by national and international standard organisations are 
met.
AST guidelines and AST interpretative criteria 
(breakpoints)
Each AST method requires specific testing conditions, 
including media, incubation time, and temperature. These 
procedures have specifically been designed for assessing 
the activity of conventional antimicrobial agents (such as 
antibiotics). Various authorities, such as EUCAST and 
Clinical and Laboratory Standards Institute (CLSI), provide 
AST guidelines for antibiotics (31–34), which promote 
development and standardisation of in vitro AST methods 
and work towards international consensus and harmonisation 
of clinical breakpoints and testing performance. These 
guidelines are also used for determining antimicrobial 
activity of plant-derived compounds, as they have no 
standards of their own. However, problems arise because 
antibiotics are generally hydrophilic, and all standardised 
AST methods have been optimised to this condition, 
whereas most polyphenols are lipophilic and are not fully 
soluble in water. This requires adjusting conventional 
EUCAST and CLSI reference methods for testing phenolic 
extracts.
Another problem arising from the use of AST guidelines 
developed for antibiotics is the absence of interpretation 
criteria (breakpoints) for susceptibility testing of plant-
derived substances. A breakpoint is the minimum drug 
concentration expected to be clinically effective against a 
microbe. It is used to describe bacterial isolates as 
susceptible, intermediate, or resistant. However, 
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interpretation criteria for polyphenol ASTs are yet to be 
established by standard-setting bodies. In the meantime, 
different criteria are used. Many studies rely on MIC. MICs 
of conventional antibiotics typically range between 0.01 
and 10 μg/mL, whereas, plant compounds are routinely 
classified as antimicrobials if their MICs range between 
100 and 1000 μg/mL. However, claiming positive activity 
for excessively high plant compound concentrations is a 
common mistake, and Rios et al. (35) propose that the MIC 
for antimicrobial activity of a plant extract and isolated 
compound to be considered significant should be below 
100 μg/mL and below 10 μg/mL, respectively. Taguri et al. 
(36) propose the following cut-off MIC values of a pure 
compound/crude extract: <400 μg/mL for strong 
antimicrobial effect, 400–800 μg/mL for moderate, and 
>800 μg/mL for weak effect.
Bouarab-Chibane et al. (37), in turn, have taken a 
different approach, as they focus on polyphenol antimicrobial 
activity against food-spoiling bacteria. They propose 
polyphenol concentration of 1000 μg/mL for a breakpoint, 
as higher concentrations would have no practical use in the 
preservation of perishable foods. This parameter of 
antimicrobial activity is called bacterial load difference 
(BLD), and its significance (breakpoint) is set at 20 % 
decrease in bacterial growth, which is achieved with 
1000 μg/mL of polyphenols.
Besides the EUCAST and CLSI standards widely used 
by clinical microbiology laboratories, European Standard 
EN 1276:2009 (38) is used to evaluate plant extracts as food 
sanitisers and European Standard EN 12054:1997 (39) to 
evaluate plant extracts as hand antiseptics.
Testing organisms and inocula
Regardless of the chosen AST method, it is necessary 
to use well-defined, standardised microbial strains obtained 
from a recognised source such as American Type Culture 
Collection (ATCC) or National Collection of Type Cultures 
(NCTC). The use of reference strains with known 
susceptibility against existing antimicrobial agents enables 
internal quality control and makes it possible to calibrate 
the test and compare results between laboratories. The 
choice of test microorganisms depends on the specific 
purpose of research. Drug-sensitive Gram-positive and 
Gram-negative reference strains of common pathogenic 
species are preferable for AST screening.
Bacterial inoculum size is the most important variable 
in antibacterial activity testing. Greater inoculum size and 
longer incubation time can result in higher antimicrobial 
MIC, which only underlines the importance of controlled 
and standardised conditions for susceptibility testing. The 
EUCAST standard recommends inoculum of 5x105 colony 
forming units (CFU)/mL for broth microdilution method 
(31). This size can be assessed by counting viable colonies. 
To do that, 10 µL of inoculum should be removed from a 
growth-control well or tube immediately after inoculation, 
diluted in 10 mL of saline, and 100 µL spread onto a non-
selective agar plate. After incubation, the number of 
colonies should be approximately 20–80. For results to be 
valid it is important that the bacteria used in AST testing 
come in the log phase of growth from a fresh culture.
In addition to growth media, bacterial strains, and 
inoculum size, there are many other factors specific for each 
type of assay (volume of agar/broth, size of wells/paper 
discs, incubation conditions, endpoints determination), 
which will be discussed with particular AST method.
COMMON IN VITRO AST METHODS
Phenotypic AST methods are either qualitative (disc 
diffusion technique) or quantitative (dilution methods, 
E-test). Phenotypic assays rely on measuring growth 
inhibition, metabolism, and viability in the presence of 
antibacterial compounds. Some methods provide quick 
results, while others allow better understanding of 
antibacterial impact on the viability and cell damage of 
tested microorganism. Conventional phenotypic AST 
methods include agar disc diffusion, well diffusion, and 
agar or broth dilution.
DIFFUSION METHODS
Agar disc diffusion assay
In the disc diffusion test (Kirby-Bauer method) the 
suspension of a microorganism in saline to the density of 
a McFarland 0.5 turbidity standard, approximately 
corresponding to 1×108 CFU/mL, is inoculated uniformly 
onto the surface of an agar plate. The density of the 
suspension is preferably measured with a photometric 
device that has been calibrated with a McFarland standard 
according to manufacturer’s instructions. Alternatively, the 
density can be compared visually to a McFarland 0.5 and 
adjusted by addition of saline or more bacteria.
A paper disc containing a standard amount of an 
antimicrobial compound is applied to the surface of the 
plate, usually MH agar, and the substance is allowed to 
diffuse into the adjacent medium. Following incubation, 
bacterial growth appears on the plate. If the test isolate is 
susceptible to antimicrobial compound, a clear area of “no 
growth” will appear around the disc. This zone is referred 
to as the zone of inhibition. Its size will depend on the 
diffusion rate of the test solution and the degree of 
sensitivity of the microorganism. Strains resistant to an 
antimicrobial compound will reach the margin of disc. 
Inhibition zone diameter is therefore used to interpret 
inhibition, and standards for interpretation have been 
established for different antibiotics. The size of the 
inhibition zone in the disc diffusion test inversely correlates 
with MIC (40).
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Pre-prepared, quality-controlled antibiotic discs provide 
reproducible and reliable findings. Unfortunately, this is 
not the case with extract-soaked filter paper discs, as they 
are not commercially available. Instead, filter paper discs 
or sterile commercial blank discs (about 6 mm in diameter) 
are impregnated with 0.01–0.02 mL of diluted test solution 
and allowed to dry before placing on top of agar plates (41). 
Drying time varies from 2 h to overnight under laminar 
flow.
The disc diffusion method for screening of natural 
products for antimicrobial activity owes its popularity to 
simple use and low cost. However, it involves a number of 
critical steps, such as the choice of the medium, pH, agar 
depth and moisture content, incubation conditions, and 
ensuring accurate inoculum density. The diameter of the 
inhibition zone may be affected by the solubility of the 
tested substance, diffusion range, and evaporation. 
Precipitation of water-insoluble substances in the disc will 
prevent any diffusion of antimicrobial substances into the 
agar. With mixtures of constituents with different diffusion 
rates, this may give unreliable results. In fact, no inhibition 
zone does not necessarily mean that the tested compound 
is ineffective, especially if we speak about less polar 
compounds, which diffuse more slowly in aqueous agar. It 
is therefore not surprising for phenolic compound AST to 
get inconsistent results. When a disc diffusion method is 
used, a correlation between a number of compound 
concentrations used and inhibition zone diameters needs to 
be established to consider it reliable (17, 42). The main 
disadvantage of the test, however, is that it is qualitative 
and does not distinguish between bactericidal and 
bacteriostatic effects. If used for antimicrobial screening, 
disc diffusion is better for low molecular weight compounds, 
whereas for high molecular weight compounds well 
diffusion is preferred (43).
Agar well diffusion assay
This method is frequently used for testing antimicrobial 
activity of plant-derived substances (44, 45). A bacterial 
isolate mixed with soft agar is poured onto a plate and 
cooled. Then wells are cut with a sterile borer (4–8 mm in 
diameter), and test substances placed into each well. After 
incubation, the plate is observed for clear zones of inhibition 
around the well. Another way is to spread inoculum 
suspension evenly on a solid agar plate and add antimicrobial 
substances into each well. Agar well diffusion seems to be 
more sensitive and convenient than the disc variant for 
testing cationic natural products, as they adsorb on the 
hydrophilic surface of the disc and not diffuse into the 
medium (43, 46).
Disc and well diffusion tests are qualitative, which 
means that they do not quantify the amount of the tested 
compound diffused in the agar medium. In view of known 
diffusion issues of non-polar compounds, both methods are 
a poor choice for AST of crude plant extracts, which often 
contain compounds with different polarities. Both have poor 
reproducibility and both often fail to yield a linear 
correlation between the inhibition zone diameter and 
antimicrobial concentration (17, 47). In such cases, 
antimicrobial activity should be determined with a 
quantitative dilution method.
Bioautography
Bioautography is a method of microbial detection 
relying on planar chromatography techniques. It can be 
used to test antimicrobial activity of plant extracts and pure 
compounds. Bioautography assays can be divided into three 
groups: (a) direct bioautography, (b) contact or agar 
diffusion bioautography, and (c) immersion or agar overlay 
bioautography. With direct bioautography microorganisms 
are grown directly on thin-layer chromatography (TLC) 
plates, which combine two uses: separation of analysed 
substances and antibacterial activity. Direct bioautography 
usually does not make use of agar gel. The plate is dipped 
in or sprayed with a seeded culture broth. Inhibition 
(bioautogram) is usually visualised thanks to tetrazolium 
salts converted to intensely coloured formazan by live 
aerobic and facultative anaerobic bacteria. For 
microaerophilic bacteria like Campylobacter spp. adenosine 
triphosphate (ATP) is a better choice, as it allows 
determination by bioluminescence (48).
Contact bioautography is a variant of agar diffusion 
often used to screen for antimicrobial activity of plant 
extracts (49–51). Unlike with other diffusion methods, the 
analyte diffuses to inoculated agar medium from the 
chromatographic layer. A sample to be analysed is first 
adsorbed on a TLC plate and then transferred from the TLC 
plate to inoculated agar surface (52).
Immersion (agar overlay) bioautography, combines 
direct and contact bioautography, as – unlike with contact 
bioautography – the seeded agar medium is applied onto 
the TLC plate (51).
Opinions about bioautography vary. Silva et al. (53) 
claim that it is practical, reproducible, and easy to perform. 
Rios et al. (54), in contrast, find bioautographic methods 
difficult to standardise, as there are many varying factors 
that affect results. Even so, bioautography has a number of 
advantages: it uses small amounts of a sample, it is suitable 
for evaluating complex lipophilic plant extracts, and it 
facilitates rapid, inexpensive, and easy evaluation (55).
Furthermore, bioautography provides information about 
antimicrobial activities of individual substances in a 
mixture. This is particularly true for TLC bioluminescence 
– a variant of direct bioautography used for rapid screening 
of complex mixtures (56). Complex mixtures are first 
separated by TLC. The TLC plate is then coated with 
bioluminescent bacteria to reveal antimicrobial activity as 
dark zones on a luminescent background. The advantage 
of this kind of separation combined with post-
chromatography bioassays is that it provides rapid and 
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sensitive screening for individual antimicrobial compounds 
in various mixtures and can also be used for toxicity 
screening (57, 58).
DILUTION METHODS
In contrast to diffusion methods, dilution methods allow 
quantitation of MIC or minimal bactericidal concentration 
(MBC). Their main disadvantage is that they require 
relatively large amounts of reagents and space.
Agar dilution method
A tested substance is mixed in various concentrations 
with the MH agar before solidification. An inoculum of 0.5 
McFarland standard density is then diluted in broth to give 
107 CFU/mL (EUCAST/CLSI guidelines) (31, 32). 1-μL 
bacterial suspensions will give a final inoculum of 104 CFU/
spot. Inoculated agar plates are then incubated and growth 
estimated by the naked eye. This technique, however, is 
tedious, labour-intensive, and takes large amounts of tested 
compounds. To address this issue Golus et al. (59) have 
proposed agar microdilution for testing oily and coloured 
plant extracts. This method combines convenience and time/
cost effectiveness typical for microtitre methods with the 
advantages of the agar dilution of hydrophobic or coloured 
substances.
Broth dilution method
In the broth macrodilution tube assay serial dilutions of 
tested compounds prepared in a liquid medium (MH broth 
or water) are mixed with bacterial suspensions in a series 
of tubes. Broth microdilution assay (also known as 
microtitre/microwell plate method) uses microwell plates 
instead. Both assays show bacterial growth inhibition with 
various compounds by measuring turbidity after overnight 
incubation. Turbidity indicates how efficient specific 
concentrations of a tested compound are in inhibiting 
bacterial growth. The less turbid a sample is in each tube 
(well), the better the bacterial growth inhibition (efficiency). 
A growth medium without antimicrobial agents serves as 
control. At the same time as assays are performed, inoculum 
control has to be determined in a medium to ensure that an 
even and sufficient number of organisms is used in the test. 
Bacterial inoculum varies in this respect and can 
significantly affect the assessment of MIC. Inocula with 
cell counts lower than 5x105 CFU/mL can show false 
susceptibility.
MBC is determined by subculturing the dilution that 
has shown no growth in the MIC assay. The selection of 
methods depends on the nature of compounds such as 
solubility and molecular weight. Although the broth 
microdilution method is the best way to establish the real 
potency of a pure compound, this will greatly depend on 
the solubility of the tested compound. Water-insoluble 
compounds disperse poorly in a liquid growth medium and 
separate to oil and water phases. Furthermore, if plant 
extract solution is turbid and coloured, it will be difficult 
to determine the endpoints of bacterial growth. If turbidity 
is measured visually, bacterial growth may be underestimated. 
In addition, precipitation of insoluble substances of the plant 
extract to the bottom of the well can sometimes make 
difficult visual or electronic turbidity measurement. This 
problem has been solved with redox indicators such as 
tetrazolium salts (60) or resazurin (61), which change colour 
with bacterial growth. The wells showing bacterial growth 
become pink, whereas the wells showing no growth remain 
colourless or blue, depending on the indicator. This 
procedure is referred to as colorimetric MIC method. In 
other words, broth microdilution methods have endpoints 
that can be determined either as a measure of turbidity or 
of cell viability indicators. Adding the indicator also helps 
to semi-automate broth microdilution through image 
processing. Using standardised bacterial inoculum Sarker 
et al. (62) have proposed a modified resazurin method, 
which corrects dilution inaccuracies, to achieve more 
accuracy in MIC determination for natural products. 
Recently, Veiga et al. (63) proposed another improved and 
validated colorimetric microdilution assay with 
triphenyltetrazolium chloride (TTC) as an indicator precise 
enough to correlate absorbance with the concentration of 
viable microorganisms and determine not only MIC but 
also 50 % and 90 % inhibitory concentrations (IC50 and 
IC90, respectively. TTC is a salt that changes colour from 
clear to pink as it is metabolised by viable bacteria. Even 
with these indicators, however, strongly coloured/opaque 
pose media make reading colour changes difficult. In such 
cases, samples from each well are plated on a solid medium 
and colonies counted.
Another recent improvement to the standard 
microdilution method was an attempt to annul the risk of a 
medium inhibiting antimicrobial activity and improve 
extract solubility at the same time (64, 65). In the first step, 
bacteria in the mid-logarithmic growth phase are washed 
twice by centrifugation, re-suspended in Tris buffer, and 
incubated with a polyphenol without a growth medium. 
After five hours of incubation, follows the second step, in 
which Tryptic soy broth is added and microplates incubated 
for another six to twelve hours, that is, until controls form 
clearly visible pellets. At this point, viable cells are counted 
to identify growth. Microplates are then left to incubate for 
a total of 48 h to confirm by visual inspection that bacterial 
growth has completely been inhibited. This two-step 
microdilution assay offers more precise evaluation of 
antimicrobial efficacy of the tested compound. In addition, 
this assay has an option to use DMSO to enhance the 
solubility of more hydrophobic compounds, which 
facilitates identification of cationic and less polar bioactive 
compounds, whereas with other compounds it yields similar 
activity readings as the standard assay (65).
Although both agar (47, 66–68) and broth dilution 
(69–72) methods are commonly used to assess antimicrobial 
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activity of plant extracts and polyphenols, broth dilution 
produces the most consistent results (17).
The broth dilution method can also be used to assess 
the lethal effect of an antimicrobial agent and provide a 




Historically, the time-kill assay (TKA) has been used 
to evaluate bactericidal properties of a new drug or other 
product that is expected to have one by monitoring bacterial 
death caused by antimicrobials at a wide range of 
concentrations (0.5–4 × MIC) over time. Briefly, 106 CFU/
mL of microorganisms are incubated with antimicrobials 
at 37 °C for predetermined sampling time (e.g. 0, 2, 4, 8, 
12, and 24 h). Aliquots (1 mL, or appropriate volume) are 
then removed from each test suspension, serially diluted 
ten times (tenfold dilution) in sterile saline, and plated on 
agar plates for colony count. The rate of bactericidal activity 
is presented as the time-kill curve or survival curve. 
Generally, a 3-log10 drop in bacterial survival is considered 
the threshold for significant killing activity against a 
particular test microorganism.
TKA can also be used to evaluate synergistic effects of 
plant compound combinations (69, 74). Combination testing 
provides information about which antimicrobials can be 
combined to achieve optimal/maximal effect. In that 
respect, TKA and checkerboard assay are most commonly 
used to assess if there is synergy between phytochemicals 
and antibiotics (75, 76). Synergy is often defined as a 
≥2 log10 decrease in the bacterial count (CFU/mL) compared 
to the most active compound tested alone (77).
Critical factors that affect the outcome of TKA include 
the preparation of an actively growing inoculum and the 
use of quantitative subcultures from drug-containing tubes. 
When high drug concentrations (≥4 x MIC) are tested, it is 
necessary to exclude the antibiotic carryover effect, which 
occurs when a tested compound transferred onto the agar 
plate with the subcultured aliquot is sufficient to inhibit the 
growth of viable microorganisms and results in a falsely 
low MBC. This phenomenon can be eliminated by widely 
streaking the transferred aliquot over at least one-half of an 
agar plate or by centrifugation and resuspension of the 
bacteria in antimicrobial-free media before plating.
Checkerboard assay
In checkerboard assay antibiotic is serially diluted along 
the abscissa and the plant compounds along the ordinate of 
microtitre plates. After inoculation and incubation, the 
plates are observed for bacterial growth and determination 
of MIC for a combination. Synergy is measured against the 
activity of individual components in a combination using 
the fractional inhibitory concentration (FIC) index, 






MICa alone MICb alone
where MICa denotes the minimum inhibitory 
concentration of a plant extract and MICb of an antibiotic, 
if the synergy of the two is being evaluated.
The resulting index quantitatively denotes synergism if 
≤0.5, additive effect if >0.5 to ≤1, or indifference if >1 (78). 
However, these indices are to be taken with reserve, as they 
involve one tube dilution variation and the possibility of 
reproducibility error. Due to inherent variability in MIC 
determination consequent inconsistent classification of the 
checkerboard assay results, Rand et al. (79) have proposed 
that a minimum of five replicates should be tested and 
≥80 % agreement achieved between them for the effect to 
be categorised.
In any case, synergy testing results obtained with 
checkerboard assay may differ from those obtained with 
TKA, as the checkerboard method yields results at one time 
point, whereas killing curves measure changes over time.
MICROFLUIDIC AST METHODS
Screening for biological activity is often limited by the 
availability of active compounds. This can be overcome by 
techniques requiring them in low quantities. Developed in 
the last decade, microfluidic-based culture methods allow 
monitoring bacterial growth in channels/chambers that take 
no more than 20 μL of tested compounds (80). Li et al. (81) 
have recently demonstrated a promising adaptable 
microfluidic system that allows rapid phenotypic AST at 
the single-cell level. This miniaturisation made possible 
with new microfluidic technologies – described in detail in 
the review article of Schumacher et al. (82) – allows them 
to be integrated with an automatic device and therefore 
improve test speed and accuracy and achieve high 
throughput. Besides phenotypic, genotypic microfluidic 
ASTs have been developed for molecular detection of drug 
resistance to conventional antibiotics.
Recently, Parsley et al. (83) found significant differences 
in the bioactivity profiles of natural product peptides against 
E. coli between a microfluidic assay and a plate-based 
method. They suggested that the differences were owed to 
different bacterial growth conditions and different plastic 
materials involved in each assay and pointed out that 
microfluidic-based methods required significant 
optimisation to be reliably applied for AST.
Even so, microfluidics bring several advantages to AST 
over classical methods that use Petri dishes and multi-well 
plates, as they makes it possible to develop high throughput, 
real-time, low sample consumption assays. The downside 
is that such assays require expensive and specialised 
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equipment and samples need several preparation steps 
before analysis (84).
OTHER CONSIDERATIONS AND FUTURE 
NEEDS
Each of the presented AST methods has advantages and 
disadvantages (Table 1) and none can be regarded as the 
universal “best” method. Instead, each is best suited to 
different needs.
New bioassays and protocols should be selective and 
precise enough to detect bioactive effects of small amounts 
of natural compounds against target pathogens. They should 
also take less time to identify potential antimicrobial 
candidates.
Many new AST methods are automated and well suited 
for routine testing of conventional antibiotics with 
conveniently prepared and formatted microdilution drug 
panels, instrumentation, and automated reading. Novel 
instruments turbidimetry/nephelometry instruments 
measuring bacterial growth reduce technical errors and 
lengthy preparation times. Automation also allows inter-
laboratory comparison and standardisation. However, these 
AST systems are not adapted to testing natural bioactive 
compounds and several attempts have recently been made 
to develop an automated system suitable for AST of plant 
extracts (85, 86) or adapt the existing ones. Recently, for 
example, Bouarab-Chibane et al. (37) successfully applied 
a self-contained incubation and high-throughput, microplate-
based microbial growth tracking system relying on optical 
density (Bioscreen CTM Automated Microbiology Growth 
Curve Analysis System, Growth Curves USA, Piscataway, 
NJ, USA) to quickly screen 35 polyphenols for activity 
against six pathogens.
In contrast, genetic methods, which are increasingly 
used for AST of antibiotics, have not yet been adapted for 
assessing microbial resistance to plant-derived substances, 
because molecular assays can only detect what is already 
known. As genetic profiling for resistance to natural 
compounds has not yet been made for all the bacteria, these 
essays are not commercially available for the time being. 
For us to develop tests for detecting resistance genes we 
first need to learn more about the mechanisms of activity 
of polyphenols and about the molecular basis of microbial 
resistance to them.
Another issue that deserves consideration is the 
applicability of in vitro testing in developing plant derived 
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Table 1 Overview of commonly used in vitro antimicrobial susceptibility testing methods
Method Advantages Disadvantages Reference
Agar disk 
diffusion 
simplicity of performance, low cost,
flexibility,
no special equipment required,
suitable for lead identification
qualitative assay,
poor level of reproducibility,
diffusion of antimicrobial substances 
may be affected, applicable only to 
fast-growing bacteria




simplicity of performance, low cost,
more sensitive and more convenient than 
the disc variant for testing of cationic 
compounds
qualitative assay,





little amount of sample required,
rapid and inexpensive evaluation, 




not suitable for synergy studies,





a number of bacterial species may be 
applied to a single dish
laborious and time consuming method,









capacity to test opaque materials,
possible automation,
the most consistent results,
the killing effect can be assessed
the possibility of errors in solution 
preparation,













substances as antimicrobial drugs. Namely, even though a 
plant compound may prove potent in vitro, it may have little 
biological activity in vivo if it does not reach the target 
tissues. Regardless of the testing method, in vitro 
measurement of antimicrobial activity does not address 
limited bioavailability for many of the larger polyphenols. 
Their activity may be affected by many host factors, such 
as biotransformation, pH, and local tissue properties (e.g. 
abscess cavity, cerebrospinal fluid, or intracellular location). 
Although most polyphenols are absorbed to some extent, 
each phenolic compound is absorbed differently. 
Polyphenols get cleaved by stomach acid and undergo 
extensive enzymatic and chemical modification during 
digestion and absorption. In fact, they reach the target in 
very low concentrations, and this is the main obstacle to be 
addressed by further research. Smaller phenolic molecules 
are metabolised so quickly that only their metabolites can 
be found in the blood. Moreover these metabolites are 
generally rapidly eliminated from the plasma (87, 88). 
Knowledge about phenolic bioavailability has increased 
over the last years, and we now know that oral bioavailability 
of polyphenols is generally between 2 and 10 % (89–94).
One promising solution to low oral bioavailability is 
the development of nanodelivery systems able to maintain 
the structural integrity of the bioactive molecules (95).
Furthermore, research should shift the focus to studying 
antimicrobial properties of phenolics in vivo (92–101). More 
animal and human experiments should be conducted in this 
field to establish general principles affecting their absorption 
in vivo.
Although naturally occurring polyphenols do not 
demonstrate toxic effects, any substance entered into the 
human body in excessive amounts can cause harm. The 
studies of polyphenols toxicity essential for the drug 
development process are also still lacking (102–105). 
Therefore, in any eventual uses of different polyphenols as 
antimicrobials, the safety aspects have to be taken into 
account as well.
To sum up, further research should focus on determining 
structure-function relationships, mechanisms of action, 
pharmacokinetic profiles, and interactions with antibiotics 
or other medicinal plants or compounds to better understand 
phenolic antimicrobial effects in vivo and optimise them 
through structural changes whether used alone or, more 
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Izazovi određivanja antimikrobnog učinka polifenola
Istraživanje antimikrobnih učinaka biljnih ekstrakata i spojeva u proteklih nekoliko desetljeća zaokuplja interes brojnih 
znanstvenika zbog sve veće otpornosti bakterija na antibiotike. Najčešći i najviše proučavani sekundarni biljni metaboliti 
su polifenoli – brojna i raznolika skupina fitokemikalija s dokazanim antibakterijskim djelovanjem. Međutim, istraživači 
koji proučavaju antimikrobni učinak prirodnih spojeva biljnoga podrijetla susreću se s brojnim preprekama, koje je 
potrebno prepoznati i izbjeći. Na rezultate ispitivanja antimikrobne osjetljivosti mogu utjecati brojni čimbenici, a izbor 
odgovarajuće metode ispitivanja od presudnog je značaja. Nepostojanje postupnika/smjernica za testiranje antimikrobnog 
učinka bioaktivnih prirodnih spojeva uvelike utječe na ujednačenost, analizu i usporedbu brojnih objavljenih rezultata. 
U načelu, samo primjena standardiziranih metoda osigurava dobivanje pouzdanih rezultata. Cilj je ovoga preglednog rada 
sustavno i kritički prikazati različite metode koje se koriste za ispitivanje antimikrobnog učinka polifenola te istaknuti 
potrebu za njihovom standardizacijom.
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